CASI PHARMACEUTICALS, INC. Deferred Income
CASI PHARMACEUTICALS, INC. had Deferred Income of $2.49 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredIncome · last filed 2023-04-26
- 2022-09-30: Deferred Income $2.49M.
- 2022-06-30: Deferred Income $2.66M.
- 2022-03-31: Deferred Income $2.82M.
- 2021-12-31: Deferred Income $2.83M.
| Period end | Deferred Income |
|---|---|
| 2022-09-30 | $2.49M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.66M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $2.82M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.83M 20-F · filed 2023-04-26 |
| 2021-09-30 | $2.34M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.35M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.33M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.35M 10-K · filed 2022-03-28 |
| 2020-09-30 | $2.27M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.20M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-30 |